- A Phase I/II Trial of DA3030 in Chemotherapy Induced Neutropenia
-
Chung HC, Rha SY, Gong SJ, Lee HY, Chung HC, Ahn CW, Chung WJ, Lee R, Choung BY, Lee SK, Chang YS, Yoo NC, Kim JH, Roh JK, Min JS, Kim BS, Park BS, Bahng MY
- KMID: 2059156
- J Korean Cancer Assoc.
- 1997 Oct;29(5):886-898.
PURPOSE: We planned to evaluate the toxicity and efficacy of DA-3030 to determine the recommended dose for phase III clinical trial based on the biologically active doses from phase I/II... -
- CITED
-
- Close
- SHARE
-
- Close
